These findings fill the limitations in the understanding of TCR and BCR repertoires’ features and suggest an immune response to the common autoantigens in SLE or RA patients, which could assist in the development of targeted biotherapy and the diagnosis of SLE and RA. The gene discussed is BCR; the disease is rheumatoid arthritis.